Cargando…
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019
A workshop entitled “Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases” was hosted by the University of Vermont Larner College of Medicine in collaboration with the National Heart, Lung and Blood Institute, the Alpha-1 Foundation, the Cystic Fibrosis Foundation, the Internat...
Autores principales: | Wagner, Darcy E., Ikonomou, Laertis, Gilpin, Sarah E., Magin, Chelsea M., Cruz, Fernanda, Greaney, Allison, Magnusson, Mattias, Chen, Ya-Wen, Davis, Brian, Vanuytsel, Kim, Rolandsson Enes, Sara, Krasnodembskaya, Anna, Lehmann, Mareike, Westergren-Thorsson, Gunilla, Stegmayr, John, Alsafadi, Hani N., Hoffman, Evan T., Weiss, Daniel J., Ryan, Amy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569162/ https://www.ncbi.nlm.nih.gov/pubmed/33123557 http://dx.doi.org/10.1183/23120541.00123-2020 |
Ejemplares similares
-
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021
por: Ikonomou, Laertis, et al.
Publicado: (2022) -
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report
por: Ryan, Amy L., et al.
Publicado: (2019) -
Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
por: Kadefors, Måns, et al.
Publicado: (2022) -
Temporal trend of autonomic nerve function and HSP27, MIF and PAI-1 in type 1 diabetes
por: Zimmerman, Malin, et al.
Publicado: (2017) -
CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)